pBR322: Difference between revisions
Jump to navigation
Jump to search
| (39 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
==At a Glance | ==At a Glance== | ||
[[Image:PBR322.jpg|thumb|400px|right|Image of pBR322. In red is the ''bla'', while blue encodes for tetracycline resistance. Green shows the origin of replication.]] | |||
<protect><!--box uid=63ce1649aab8b3180235b0af7618f667.0.L46c9dd5aaa84f--> | <protect><!--box uid=63ce1649aab8b3180235b0af7618f667.0.L46c9dd5aaa84f--> | ||
<!-- | <!-- | ||
****************************************************************************************** | ****************************************************************************************** | ||
* | * | ||
* ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | * ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | ||
* | * | ||
****************************************************************************************** --> | ****************************************************************************************** --> | ||
{|{{Prettytable}} | {| {{Prettytable}} width='30%' align=left id="L46c9dd5aaa84f" class=" tableEdit PlasmidTable" | ||
|- | |- | ||
!{{table heading style}} |Type | !align=left {{table heading style}} |Type | ||
| | || | ||
Cloning | Cloning | ||
|- | |- | ||
!{{table heading style}} |Origin | !align=left {{table heading style}} |Origin of Replication | ||
| | || | ||
ColE1 | ColE1 | ||
|- | |- | ||
!{{table heading style}} |Copy # | !align=left {{table heading style}} |Copy # | ||
| | || | ||
20 per cell | 20 per cell | ||
|- | |- | ||
!{{table heading style}} |Markers | !align=left {{table heading style}} |Markers | ||
| | || | ||
Tetracycline | Tetracycline | ||
Ampicillin | Ampicillin | ||
|- | |- | ||
!{{table heading style}} | | !align=left {{table heading style}} |Link to Sequence | ||
| | || | ||
[http://www.ncbi.nlm.nih.gov/nuccore/208958?report=fasta GenBank] | |||
|- | |||
!align=left {{table heading style}} |Features | |||
|| | |||
Can be amplified with chloramphenicol or spectinomycin | Can be amplified with chloramphenicol or spectinomycin | ||
|- | |- | ||
!{{table heading style}} | | !align=left {{table heading style}} |Accession Number | ||
| | || | ||
[http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=208958 J01749] | |||
|- | |- class="tableEdit_footer" | ||
| | |<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=63ce1649aab8b3180235b0af7618f667.0.L46c9dd5aaa84f&page=112262&pagename={{FULLPAGENAMEE}}&type=1&template=PlasmidTable edit table]</span> || | ||
|} | |} | ||
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.L46c9dd5aaa84f--></protect> | <!--box uid=63ce1649aab8b3180235b0af7618f667.0.L46c9dd5aaa84f--></protect> | ||
<BR> | |||
<Br clear='all'> | |||
==History {{HelpIcon|Help:Plasmid}}== | ==History {{HelpIcon|Help:Plasmid}}== | ||
{{PlasmidHistory}} | {{PlasmidHistory}} | ||
==Sources | ==Sources== | ||
[http://www.invitrogen.com Invitrogen] | |||
[http://www.promega.com/products/biochemicals-and-labware/nucleic-acids/pbr322-vector/ Promega] | |||
[https://www.roche-applied-science.com/cfm/prodsrch-index.jsp?SearchTerm=pBR322+DNA&filter_all=on Roche Applied Science] | |||
==Sequence== | |||
TTCTCATGTTTGACAGCTTATCATCGATAAGCTTTAATGCGGTAGTTTATCACAGTTAAATTGCTAACGCAGTCAGGCACCGTGTATGAAA | TTCTCATGTTTGACAGCTTATCATCGATAAGCTTTAATGCGGTAGTTTATCACAGTTAAATTGCTAACGCAGTCAGGCACCGTGTATGAAA | ||
TCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATGCTGTAGGCATAGGCTTGGTTATGCCGGTACTGCCGGGCCTCTTGC | TCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATGCTGTAGGCATAGGCTTGGTTATGCCGGTACTGCCGGGCCTCTTGC | ||
| Line 94: | Line 107: | ||
TCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTG | TCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTG | ||
CCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAA | CCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAA | ||
==References== | ==References== | ||
<ref name='PMID: 344137'/> | |||
<ref name='PMID: 3063608'/> | |||
<ref name='PMID: 358200'/> | |||
<ref name='PMID: 383387'/> | |||
<ref name='PMID: 388421'/> | |||
<ref name='PMID: 6263753'/> | |||
<ref name='PMID: 6279609'/> | |||
<ref name='PMID: 6178738'/> | |||
<ref name='PMID: 6291045'/> | |||
<ref name='PMID: 6790191'/> | |||
<ref name='PMID: 6307828'/> | |||
<ref name='PMID: 6300094'/> | |||
<ref name='PMID: 6337373'/> | |||
<ref name='PMID: 6196777'/> | |||
<ref name='PMID: 6417654'/> | |||
<ref name='PMID: 6091903'/> | |||
<ref name='PMID: 6327214'/> | |||
<ref name='PMID: 6086258'/> | |||
<ref name='PMID: 6209275'/> | |||
<ref name='PMID: 6150042'/> | |||
<ref name='PMID: 6089341'/> | |||
<ref name='PMID: 3063608'/> | |||
<references/> | <references/> | ||
| Line 106: | Line 136: | ||
[[Category:Plasmids]] | [[Category:Plasmids]][[Category:Cloning Plasmids]][[Category:Invitrogen Plasmids]][[Category:Promega Plasmids]][[Category:Ampicillin Marker Plasmids]][[Category:Tetracycline Marker Plasmids]] | ||
Latest revision as of 16:56, 25 August 2011
At a Glance

| Type |
Cloning |
|---|---|
| Origin of Replication |
ColE1 |
| Copy # |
20 per cell |
| Markers |
Tetracycline Ampicillin |
| Link to Sequence | |
| Features |
Can be amplified with chloramphenicol or spectinomycin |
| Accession Number | |
| edit table |
History
You can help EcoliWiki by writing about the history of this plasmid.
Sources
Sequence
TTCTCATGTTTGACAGCTTATCATCGATAAGCTTTAATGCGGTAGTTTATCACAGTTAAATTGCTAACGCAGTCAGGCACCGTGTATGAAA TCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATGCTGTAGGCATAGGCTTGGTTATGCCGGTACTGCCGGGCCTCTTGC GGGATATCGTCCATTCCGACAGCATCGCCAGTCACTATGGCGTGCTGCTAGCGCTATATGCGTTGATGCAATTTCTATGCGCACCCGTTCT CGGAGCACTGTCCGACCGCTTTGGCCGCCGCCCAGTCCTGCTCGCTTCGCTACTTGGAGCCACTATCGACTACGCGATCATGGCGACCACA CCCGTCCTGTGGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCA CCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTT GGGCGCCATCTCCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGTCG CATAAGGGAGAGCGTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCAC TTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGC GACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGC GAGAAGCAGGCCATTATCGCCGGCATGGCGGCCGACGCGCTGGGCTACGTCTTGCTGGCGTTCGCGACGCGAGGCTGGATGGCCTTCCCCA TTATGATTCTTCTCGCTTCCGGCGGCATCGGGATGCCCGCGTTGCAGGCCATGCTGTCCAGGCAGGTAGATGACGACCATCAGGGACAGCT TCAAGGATCGCTCGCGGCTCTTACCAGCCTAACTTCGATCATTGGACCGCTGATCGTCACGGCGATTTATGCCGCCTCGGCGAGCACATGG AACGGGTTGGCATGGATTGTAGGCGCCGCCCTATACCTTGTCTGCCTCCCCGCGTTGCGTCGCGGTGCATGGAGCCGGGCCACCTCGACCT GAATGGAAGCCGGCGGCACCTCGCTAACGGATTCACCACTCCAAGAATTGGAGCCAATCAATTCTTGCGGAGAACTGTGAATGCGCAAACC AACCCTTGGCAGAACATATCCATCGCGTCCGCCATCTCCAGCAGCCGCACGCGGCGCATCTCGGGCAGCGTTGGGTCCTGGCCACGGGTGC GCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGGGGTTGCCTTACTGGTTAGCAGAATGAATCACCGATACGCGAGCGAAC GTGAAGCGACTGCTGCTGCAAAACGTCTGCGACCTGAGCAACAACATGAATGGTCTTCGGTTTCCGTGTTTCGTAAAGTCTGGAAACGCGG AAGTCAGCGCCCTGCACCATTATGTTCCGGATCTGCATCGCAGGATGCTGCTGGCTACCCTGTGGAACACCTACATCTGTATTAACGAAGC GCTGGCATTGACCCTGAGTGATTTTTCTCTGGTCCCGCCGCATCCATACCGCCAGTTGTTTACCCTCACAACGTTCCAGTAACCGGGCATG TTCATCATCAGTAACCCGTATCGTGAGCATCCTCTCTCGTTTCATCGGTATCATTACCCCCATGAACAGAAATCCCCCTTACACGGAGGCA TCAGTGACCAAACAGGAAAAAACCGCCCTTAACATGGCCCGCTTTATCAGAAGCCAGACATTAACGCTTCTGGAGAAACTCAACGAGCTGG ACGCGGATGAACAGGCAGACATCTGTGAATCGCTTCACGACCACGCTGATGAGCTTTACCGCAGCTGCCTCGCGCGTTTCGGTGATGACGG TGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCA GCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCA GATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCG CTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGG ATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCG CCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGA AGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATA GCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGC CTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCG AGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGA AGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCA GATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGG ATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCC CGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGAT TTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCC GGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTGCAGGCATCGTGGTGTCACGCTCGTCGTTTGG TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCT CCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAA GATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAACACG GGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTG TTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAG GAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTA TCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTG CCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAA
References
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [2]
- ↑ Bolivar, F et al. (1977) Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2 95-113 PubMed
- ↑ 2.0 2.1 Watson, N (1988) A new revision of the sequence of plasmid pBR322. Gene 70 399-403 PubMed
- ↑ Sutcliffe, JG (1978) Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. U.S.A. 75 3737-41 PubMed
- ↑ Sutcliffe, JG (1979) Complete nucleotide sequence of the Escherichia coli plasmid pBR322. Cold Spring Harb. Symp. Quant. Biol. 43 Pt 1 77-90 PubMed
- ↑ Reed, RR et al. (1979) Transposition of the Escherichia coli insertion element gamma generates a five-base-pair repeat. Proc. Natl. Acad. Sci. U.S.A. 76 4882-6 PubMed
- ↑ Covarrubias, L et al. () Construction and characterization of new cloning vehicles. V. Mobilization and coding properties of pBR322 and several deletion derivatives including pBR327 and pBR328. Gene 13 25-35 PubMed
- ↑ Marians, KJ et al. (1982) Maximal limits of the Escherichia coli replication factor Y effector site sequences in pBR322 DNA. J. Biol. Chem. 257 5656-62 PubMed
- ↑ Brosius, J et al. (1982) Precise location of two promoters for the beta-lactamase gene of pBR322. S1 mapping of ribonucleic acid isolated from Escherichia coli or synthesized in vitro. J. Biol. Chem. 257 9205-10 PubMed
- ↑ Van Dyke, MW et al. (1982) Map of distamycin, netropsin, and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA.Fe(II). Proc. Natl. Acad. Sci. U.S.A. 79 5470-4 PubMed
- ↑ Larrouy, G et al. (1981) [Obtaining intraerythrocytic forms of Plasmodium vivax by in vitro culture]. C R Seances Acad Sci III 292 929-30 PubMed
- ↑ Peden, KW () Revised sequence of the tetracycline-resistance gene of pBR322. Gene 22 277-80 PubMed
- ↑ Watabe, H et al. (1983) A new class of site-specific endodeoxyribonucleases. Endo.Sce I isolated from a eukaryote, Saccharomyces cerevisiae. J. Biol. Chem. 258 4663-5 PubMed
- ↑ Livneh, Z (1983) Directed mutagenesis method for analysis of mutagen specificity: application to ultraviolet-induced mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 80 237-41 PubMed
- ↑ Mascharak, PK et al. (1983) Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. U.S.A. 80 6795-8 PubMed
- ↑ Schultz, PG & Dervan, PB (1983) Sequence-specific double-strand cleavage of DNA by penta-N-methylpyrrolecarboxamide-EDTA X Fe(II). Proc. Natl. Acad. Sci. U.S.A. 80 6834-7 PubMed
- ↑ Fuller, RS et al. (1984) The dnaA protein complex with the E. coli chromosomal replication origin (oriC) and other DNA sites. Cell 38 889-900 PubMed
- ↑ Lathe, R et al. (1984) Linker tailing: unphosphorylated linker oligonucleotides for joining DNA termini. DNA 3 173-82 PubMed
- ↑ Gonzalez, B et al. (1984) Electron microscopy mapping of Escherichia coli RNA polymerase-binding sites on plasmids from thermophilic bacteria. DNA 3 251-7 PubMed
- ↑ Abarzúa, P et al. (1984) Mutational analysis of primosome assembly sites. I. Distinct classes of mutants in the pBR322 Escherichia coli factor Y DNA effector sequences. J. Biol. Chem. 259 14286-92 PubMed
- ↑ Soeller, W et al. (1984) Mutational analysis of primosome assembly sites. II. Role of secondary structure in the formation of active sites. J. Biol. Chem. 259 14293-300 PubMed
- ↑ Van Dyke, MM & Dervan, PB (1984) Echinomycin binding sites on DNA. Science 225 1122-7 PubMed